Novo Nordisk A/S
Overview
Novo Nordisk A/S is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. The company is also involved in the development and manufacture of treatments for obesity, hemophilia, growth disorders, and other serious chronic conditions.
Core services & business areas
Therapeutic areas
FDA compliance signals
5 FDA enforcement records linked to this company.
- 4832013-09-03
Procedures for sterile drug products
- 4832013-09-03
Complete test data included in records
- 4832013-09-03
Scientifically sound laboratory controls
- 4832013-09-03
Complaint Handling Procedure
- warning_letter2012-12-12
FDA Warning Letter (drug product)
Is this Novo Nordisk A/S? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.